Richard W.J. Groen

4.9k total citations
69 papers, 3.0k citations indexed

About

Richard W.J. Groen is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Richard W.J. Groen has authored 69 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Hematology, 34 papers in Molecular Biology and 33 papers in Oncology. Recurrent topics in Richard W.J. Groen's work include Multiple Myeloma Research and Treatments (34 papers), CAR-T cell therapy research (16 papers) and Immune Cell Function and Interaction (13 papers). Richard W.J. Groen is often cited by papers focused on Multiple Myeloma Research and Treatments (34 papers), CAR-T cell therapy research (16 papers) and Immune Cell Function and Interaction (13 papers). Richard W.J. Groen collaborates with scholars based in Netherlands, United States and United Kingdom. Richard W.J. Groen's co-authors include Tuna Mutis, Anton C. Martens, Niels W.C.J. van de Donk, Paul W.H.I. Parren, Jeroen J. Lammerts van Bueren, Huipin Yuan, Henk M. Lokhorst, Marije B. Overdijk, Sonja Zweegman and Joost D. de Bruijn and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Richard W.J. Groen

66 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard W.J. Groen Netherlands	28	1.6k	1.5k	1.3k	830	386	69	3.0k
Amy Axel United States	17	1.4k 0.9×	944 0.6×	892 0.7×	530 0.6×	379 1.0×	29	2.3k
Jeroen J. Lammerts van Bueren Netherlands	19	1.2k 0.7×	899 0.6×	850 0.6×	689 0.8×	790 2.0×	24	2.2k
Max Jan United States	14	1.1k 0.7×	724 0.5×	1.0k 0.8×	1.4k 1.6×	121 0.3×	28	2.9k
Inger S. Nijhof Netherlands	15	1.0k 0.6×	1.3k 0.8×	737 0.6×	555 0.7×	363 0.9×	37	1.9k
Antonio Sacco United States	33	1000 0.6×	1.6k 1.1×	2.6k 2.0×	783 0.9×	96 0.2×	111	4.3k
Patricia Maiso United States	24	810 0.5×	1.3k 0.8×	2.0k 1.5×	600 0.7×	84 0.2×	64	3.1k
Michel de Weers Netherlands	12	657 0.4×	1.0k 0.7×	618 0.5×	720 0.9×	320 0.8×	28	1.7k
Kenneth Wen United States	16	787 0.5×	740 0.5×	570 0.4×	427 0.5×	209 0.5×	52	1.3k
Jens-Peter Volkmer United States	21	818 0.5×	359 0.2×	829 0.6×	2.0k 2.4×	99 0.3×	37	3.0k
Els Van Valckenborgh Belgium	36	1.1k 0.7×	1.3k 0.8×	1.8k 1.4×	610 0.7×	53 0.1×	77	2.9k

Countries citing papers authored by Richard W.J. Groen

Since Specialization

Citations

This map shows the geographic impact of Richard W.J. Groen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard W.J. Groen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard W.J. Groen more than expected).

Fields of papers citing papers by Richard W.J. Groen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard W.J. Groen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard W.J. Groen. The network helps show where Richard W.J. Groen may publish in the future.

Co-authorship network of co-authors of Richard W.J. Groen

This figure shows the co-authorship network connecting the top 25 collaborators of Richard W.J. Groen. A scholar is included among the top collaborators of Richard W.J. Groen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard W.J. Groen. Richard W.J. Groen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Jiaxian, Ricardo De Matos Simoes, Ruud Ruiter, et al.. (2025). Humanized Bone Model Identifies BMP6 as a Multifunctional Regulator in Myeloma Bone Disease. Biomolecules. 15(12). 1747–1747.

Arkel, Jennemiek van, Afroditi Katsarou, Ruud Ruiter, et al.. (2023). Specific Targeting of Multiple Myeloma by Dual Split-signaling Chimeric Antigen Receptor T cells Directed against CD38 and CD138. Clinical Cancer Research. 29(20). 4219–4229. 10 indexed citations

Katsarou, Afroditi, Renée Poels, Esther Drent, et al.. (2021). Bone Marrow Mesenchymal Stromal Cells Can Render Multiple Myeloma Cells Resistant to Cytotoxic Machinery of CAR T Cells through Inhibition of Apoptosis. Clinical Cancer Research. 27(13). 3793–3803. 47 indexed citations

Werf, Inge van der, Anna Wojtuszkiewicz, Huilan Yao, et al.. (2021). SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia. Leukemia. 35(9). 2698–2702. 8 indexed citations

Varela-Moreira, Aida, Demian van Straten, Ruud Ruiter, et al.. (2020). Polymeric micelles loaded with carfilzomib increase tolerability in a humanized bone marrow-like scaffold mouse model. International Journal of Pharmaceutics X. 2. 100049–100049. 15 indexed citations

Katsarou, Afroditi, Maria Sjöstrand, Renée Poels, et al.. (2020). Co-Targeting CD38 with a Chimeric Costimulatory Receptor Enhances Adoptive T Cell Therapy for Hematological Malignancies. Pure Amsterdam UMC. 28(4). 40–41. 1 indexed citations

Drent, Esther, Renée Poels, Ruud Ruiter, et al.. (2019). Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor–engineered T Cells. Clinical Cancer Research. 25(13). 4014–4025. 135 indexed citations

Krejcik, Jakub, Inger S. Nijhof, Berris van Kessel, et al.. (2017). Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with Daratumumab. Clinical Cancer Research. 23(24). 7498–7511. 119 indexed citations

Cholujová, Dana, Zdenka Lukáčová Bujňáková, Erika Dutková, et al.. (2017). Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myeloma. British Journal of Haematology. 179(5). 756–771. 31 indexed citations

10.

Nijhof, Inger S., Tineke Casneuf, Berris van Kessel, et al.. (2016). CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma. Blood. 128(7). 959–970. 275 indexed citations

11.

Overdijk, Marije B., J.H. Marco Jansen, Maaike Nederend, et al.. (2016). The Therapeutic CD38 Monoclonal Antibody Daratumumab Induces Programmed Cell Death via Fcγ Receptor–Mediated Cross-Linking. The Journal of Immunology. 197(3). 807–813. 196 indexed citations

12.

Overdijk, Marije B., Sandra Verploegen, Marijn Bögels, et al.. (2015). Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma. mAbs. 7(2). 311–320. 370 indexed citations

13.

Drent, Esther, Richard W.J. Groen, Willy A. Noort, et al.. (2014). CD38 Chimeric Antigen Receptor Engineered T Cells As Therapeutic Tools for Multiple Myeloma. Blood. 124(21). 4759–4759. 6 indexed citations

14.

Guichelaar, Teun, Maarten E. Emmelot, Henk Rozemuller, et al.. (2013). Human Regulatory T Cells Do Not Suppress the Antitumor Immunity in the Bone Marrow: A Role for Bone Marrow Stromal Cells in Neutralizing Regulatory T Cells. Clinical Cancer Research. 19(6). 1467–1475. 22 indexed citations

15.

Donk, Niels W.C.J. van de, Monique C. Minnema, Julie H. Huang, et al.. (2013). Accessory Cells of the Microenvironment Protect Multiple Myeloma from T-Cell Cytotoxicity through Cell Adhesion-Mediated Immune Resistance. Clinical Cancer Research. 19(20). 5591–5601. 51 indexed citations

16.

Reijmers, Rogier M., Richard W.J. Groen, Annemieke Kuil, et al.. (2011). Disruption of heparan sulfate proteoglycan conformation perturbs B-cell maturation and APRIL-mediated plasma cell survival. Blood. 117(23). 6162–6171. 45 indexed citations

17.

Groen, Richard W.J., Frans M.A. Hofhuis, Berris van Kessel, et al.. (2010). In Vitro and In Vivo Efficacy of CD38 Directed Therapy with Daratumumab In the Treatment of Multiple Myeloma. Blood. 116(21). 3058–3058. 3 indexed citations

18.

Spaapen, Robbert M., Richard W.J. Groen, Teun Guichelaar, et al.. (2010). Eradication of Medullary Multiple Myeloma by CD4+ Cytotoxic Human T Lymphocytes Directed at a Single Minor Histocompatibility Antigen. Clinical Cancer Research. 16(22). 5481–5488. 11 indexed citations

19.

Reijmers, Rogier M., Richard W.J. Groen, Henk Rozemuller, et al.. (2009). Targeting EXT1 reveals a crucial role for heparan sulfate in the growth of multiple myeloma. Blood. 115(3). 601–604. 40 indexed citations

20.

Groen, Richard W.J., Monique E.C.M. Oud, Esther J.M. Schilder-Tol, et al.. (2008). Illegitimate WNT Pathway Activation by β-Catenin Mutation or Autocrine Stimulation in T-Cell Malignancies. Cancer Research. 68(17). 6969–6977. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact